ATE234614T1 - Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren - Google Patents

Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren

Info

Publication number
ATE234614T1
ATE234614T1 AT96917093T AT96917093T ATE234614T1 AT E234614 T1 ATE234614 T1 AT E234614T1 AT 96917093 T AT96917093 T AT 96917093T AT 96917093 T AT96917093 T AT 96917093T AT E234614 T1 ATE234614 T1 AT E234614T1
Authority
AT
Austria
Prior art keywords
selegiline
mammals
hearing loss
treat hearing
treat
Prior art date
Application number
AT96917093T
Other languages
English (en)
Inventor
William W Ruehl
David R Stevens
Original Assignee
Deprenyl Animal Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deprenyl Animal Health Inc filed Critical Deprenyl Animal Health Inc
Application granted granted Critical
Publication of ATE234614T1 publication Critical patent/ATE234614T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
AT96917093T 1995-06-07 1996-06-03 Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren ATE234614T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/475,186 US5561163A (en) 1990-08-31 1995-06-07 Treating hearing loss with deprenyl
PCT/US1996/008642 WO1996040094A1 (en) 1995-06-07 1996-06-03 Use of selegiline to treat hearing loss in mammals

Publications (1)

Publication Number Publication Date
ATE234614T1 true ATE234614T1 (de) 2003-04-15

Family

ID=23886552

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96917093T ATE234614T1 (de) 1995-06-07 1996-06-03 Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren

Country Status (9)

Country Link
US (1) US5561163A (de)
EP (1) EP0831798B1 (de)
JP (1) JP3094305B2 (de)
AT (1) ATE234614T1 (de)
AU (1) AU693704B2 (de)
CA (1) CA2221255C (de)
DE (1) DE69626816T2 (de)
ES (1) ES2194104T3 (de)
WO (1) WO1996040094A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005102345A1 (en) * 2004-03-30 2005-11-03 Alcon, Inc. Use of rho kinase inhibitors in the treatment of hearing loss, tinnitus and improving body balance
BRPI0511722A (pt) 2004-06-01 2008-01-08 Hoffmann La Roche 3-amino-1-arilpropilindóis como inibidores da recaptação de monoamina
DK2970890T3 (da) 2013-03-14 2020-05-04 Brigham & Womens Hospital Inc Sammensætninger og fremgangsmåder til opformering og dyrkning af epitelstamceller
WO2016037016A1 (en) 2014-09-03 2016-03-10 The Brigham And Women's Hospital, Inc. Compositions, systems, and methods for generating inner ear hair cells for treatment of hearing loss
JP2019506153A (ja) 2016-01-08 2019-03-07 マサチューセッツ インスティテュート オブ テクノロジー 分化した腸内分泌細胞およびインスリン産生細胞の作製
US11260130B2 (en) 2016-03-02 2022-03-01 Frequency Therapeutics, Inc. Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using a GSK3 inhibitor: IV
US10201540B2 (en) 2016-03-02 2019-02-12 Frequency Therapeutics, Inc. Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using GSK3 inhibitors: I
US10213511B2 (en) 2016-03-02 2019-02-26 Frequency Therapeutics, Inc. Thermoreversible compositions for administration of therapeutic agents
MX390321B (es) 2016-12-30 2025-03-20 Frequency Therapeutics Inc Compuestos de 1h-pirrol-2,5-diona y metodos de uso de los mismos para inducir la auto-renovacion de celulas madre/progenitoras de soporte.
WO2020037326A1 (en) 2018-08-17 2020-02-20 Frequency Therapeutics, Inc. Compositions and methods for generating hair cells by downregulating foxo
JP2021533788A (ja) 2018-08-17 2021-12-09 フリークエンシー セラピューティクス インコーポレイテッド Ｊａｇ−１を上方制御することにより有毛細胞を生成するための組成物及び方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA871155A (en) * 1971-05-18 Chinoin Gyogyszer-Es Vegyeszeti Termekek Gyara Rt Optically active phenyl isopropylamine derivatives having pharmaceutical properties and their preparation
HU187775B (en) * 1982-07-14 1986-02-28 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu New process for producing propargile-amines of pharmaceutical activity
HU193662B (en) * 1983-12-20 1987-11-30 Chinoin Gyogyszer Es Vegyeszet Process for producing synergetic pharmaceutical composition of antidepressive aktivity
US4916151A (en) * 1985-12-05 1990-04-10 Merrell Dow Pharmaceuticals Inc. Method of treating parkinson's syndrome
US4871550A (en) * 1986-09-05 1989-10-03 Millman Phillip L Nutrient composition for athletes and method of making and using the same
US4861800A (en) * 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
US5192808A (en) * 1990-08-31 1993-03-09 Deprenyl Animal Health, Inc. Therapeutic effect of L-deprenyl in the management of pituitary-dependent hyperadrenocorticism (cushing's disease)
CA2039194C (en) * 1990-08-31 1997-01-28 Norton W. Milgram Uses of l-deprenyl and compositions for same
SE9301112D0 (sv) * 1993-04-02 1993-04-02 Orion-Yhtymae Oy A new composition

Also Published As

Publication number Publication date
CA2221255C (en) 2005-11-08
JP3094305B2 (ja) 2000-10-03
WO1996040094A1 (en) 1996-12-19
AU693704B2 (en) 1998-07-02
EP0831798B1 (de) 2003-03-19
DE69626816T2 (de) 2004-02-05
ES2194104T3 (es) 2003-11-16
DE69626816D1 (de) 2003-04-24
US5561163A (en) 1996-10-01
CA2221255A1 (en) 1996-12-19
JPH10510843A (ja) 1998-10-20
EP0831798A1 (de) 1998-04-01
AU5977296A (en) 1996-12-30

Similar Documents

Publication Publication Date Title
EE9700225A (et) Meetod diabetes mellituse raviks, kasutades KKF
ATE254405T1 (de) Stoff zur erhöhung der effizienz der vermehrung und der produktion von säugetieren
DE69733132D1 (de) Verwendung von antioxidantien zur behandlung cholestatischer lebererkrankungen
BG100960A (bg) Дозирани форми с контролирано освобождаване на азитромицин
NZ330860A (en) Method of inhibiting photoaging of skin
ATE225176T1 (de) Verwendung von serotonin-antagonisten (5ht3) zur behandlung von fibromyalgie
ATE279181T1 (de) Verwendung von 5ht-6 antagonisten zur behandlung adhd
DE59409832D1 (de) Pflaster zur behandlung von nagelmykosen
DE69827001D1 (de) Gewebedezellularization
DE59509848D1 (de) Kombinationspräparat zur anwendung bei immunologischen erkrankungen
ID22042A (id) Benzonaftiridin sebagai pengobatan cabang tenggorokan
TR200000755T2 (tr) Karşıt olma-karşı gelme bozukluğunun tedavisi.
ATE311853T1 (de) Verwendung von krillenzymen zur behandlung von zahnbelag
ATE169445T1 (de) Verwendung von gelformulierungen als beizmittel
DE69626816D1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
ATE218862T1 (de) Verwendung von 1-hydroxy-2-pyridonen zur behandlung von hautinfektionen
DE69716434D1 (de) Verwendung von lysin zur behandlung des haarausfalls
ATE251462T1 (de) Verfahren zur behandlung von narbengewebe
ATE278401T1 (de) Verwendung von riluzol zur behandlung von akustischen traumazuständen
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
ES2153584T3 (es) Piridiniminil-1,2-benzisoxazol y -benzisotiazol como antipsicoticos.
DE69936779D1 (de) Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
DE69712287D1 (de) Verwendung von Sulbutiamin zur Behandlung von psychomotorischen oder psychointellektuellen Beschwerden
NO984198L (no) FremgangsmÕte for behandling av aggresjon

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties